Health Care & Life Sciences » Pharmaceuticals | Wound Management Technologies Inc.

Wound Management Technologies Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
1,726.40
2,632.60
3,372.20
5,507.90
6,304.70
Cost of Goods Sold (COGS) incl. D&A
844.40
860.10
952.00
1,004.50
886.70
Gross Income
882.00
1,772.60
2,420.20
4,503.40
5,418.10
SG&A Expense
3,720.40
3,835.10
3,385.20
4,775.50
5,297.60
EBIT
2,838.40
2,062.50
965.00
272.10
120.50
Unusual Expense
467.60
78.10
198.60
30.90
337.60
Non Operating Income/Expense
9.80
-
-
0.00
0.10
Interest Expense
1,787.20
293.90
176.90
174.50
126.80
Pretax Income
4,148.10
2,278.20
1,340.50
415.70
331.30
Consolidated Net Income
4,148.10
2,278.20
1,340.50
415.70
331.30
Net Income
4,148.10
2,278.20
1,340.50
415.70
331.30
Net Income After Extraordinaries
4,148.10
2,278.20
1,340.50
415.70
331.30
Net Income Available to Common
4,154.40
2,512.00
1,609.20
677.50
192.30
EPS (Basic)
0.05
0.03
0.02
0.01
0.00
Basic Shares Outstanding
77,710.70
93,082.20
106,695.80
108,604.50
111,381.80
EPS (Diluted)
0.05
0.03
0.02
0.01
0.00
Diluted Shares Outstanding
77,710.70
93,082.20
106,695.80
108,604.50
208,645.50
EBITDA
2,786.70
2,006.10
905.00
211.30
201.10
Non-Operating Interest Income
-
0.10
0.00
-
-
Preferred Dividends
6.30
233.80
268.80
261.70
139.00

About Wound Management Technologies

View Profile
Address
1200 Summit Avenue
Fort Worth Texas 76102
United States
Employees -
Website http://www.wmgtech.com
Updated 09/14/2018
Wound Management Technologies, Inc. develops, markets and distributes biotechnology products to physicians, hospitals and clinics. It focuses on the distribution of patented collagen product, CellerateRX, Surgical Activated Collagen and HemaQuell which is FDA cleared and reimbursable under medicare part B. he company was founded by Scott A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.